Effects of Intra-articular Infiltration of Proteoglycan 4 / Lubricin in Temporomandibular Joint Osteoarthritis: An Experimental Study

Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Objective : The proposed research aims to evaluate the histopathological effects of intra-articular administration of recombinant human proteoglycan 4 (rhPRG4) on articular cartilage and articular disc in an experimental model of induced temporomandibular joint osteoarthritis (TMJ-OA) in rabbits. Materials and Methods: An experimental study was conducted on twenty-four rabbits’ TMJs, distributed in: 1) TMJ-C, control group consisting of 4 healthy TMJs; 2) TMJ-OA, group consisting of 5 TMJs with OA; 3) TMJ-OA-WT, group consisting of 5 untreated TMJ-OAs; 4) rhPRG4-30, group consisting of 5 ATM with OA treated with lubricin 30 μg /ml; and 5) rhPRG4-100, group consisting of 5 ATM with OA treated with lubricin 100 μg/ml. A histopathological analysis was performed, considering the mandibular condyle, articular disc, and mandibular fossa, comparing the groups. In addition, a quantitative comparative analysis was performed using the Osteoarthritis Research Society International (OARSI) scale. The Kruskal-Wallis and Dunn's post hoc tests were used for statistical analysis, considering a statistical significance of p < 0.05. Results: Descriptive histological analysis of TMJ joint tissue reveals key differences between healthy, osteoarthritic, and rhPRG4-treated joints. The analysis also suggests beneficial treatment effects with intra-articular infiltration of rhPRG4, reducing the severity of osteoarthritis. Conclusions : Intra-articular infiltration of rhPRG4 in TMJ-OA has a cartilage and articular disc repair effect, reducing the severity of osteoarthritis and promoting a more organized cartilage structure, with slightly better results at the 30 μg/ml concentration. Clinical Relevance: Intra-articular infiltration of rhPRG4 is proposed as a new therapeutic alternative in TMJ-OA, enhancing joint tissue regeneration.

Article activity feed